Literature DB >> 18991630

Environmental chemicals and breast cancer risk--a structural chemistry perspective.

Jamie Weyandt1, Rachel E Ellsworth, Jeffrey A Hooke, Craig D Shriver, Darrell L Ellsworth.   

Abstract

In modern industrialized societies, people are exposed to thousands of naturally occurring and synthetic chemicals throughout their lifetime. Although certain occupational chemicals are known to be carcinogenic in humans, it has been difficult to definitively determine the adverse health effects of many environmental pollutants due to their tremendous chemical diversity and absence of a consistent structural motif. Many environmental chemicals are metabolized in the body to reactive intermediates that readily react with DNA to form modified bases known as adducts, while other compounds mimic the biological function of estrogen. Because environmental chemicals tend to accumulate in human tissues and have carcinogenic and/or estrogenic properties, there is heightened interest in determining whether environmental chemicals increase risk for endocrine-related cancers, including breast cancer. Breast cancer is the most common cancer in women worldwide, but established risk factors account for a relatively small proportion of cases and causative factors remain ambiguous and poorly defined. In this review, we outline the structural chemistry of environmental contaminants, describe mechanisms of carcinogenesis and molecular pathways through which these chemicals may exert detrimental health effects, review current knowledge of relationships between chemicals and breast cancer risk, and highlight future directions for research on environmental contributions to breast cancer. Improved understanding of the relationship between environmental chemicals and breast cancer will help to educate the general public about real and perceived dangers of these pollutants in our environment and has the potential to reduce individual risk by changing corporate practices and improving public health policies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991630     DOI: 10.2174/092986708786242930

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  5 in total

1.  Endocrine disruptors fludioxonil and fenhexamid stimulate miR-21 expression in breast cancer cells.

Authors:  Yun Teng; Tissa T Manavalan; Chuan Hu; Svjetlana Medjakovic; Alois Jungbauer; Carolyn M Klinge
Journal:  Toxicol Sci       Date:  2012-10-10       Impact factor: 4.849

2.  Exposure to estrogen and ionizing radiation causes epigenetic dysregulation, activation of mitogen-activated protein kinase pathways, and genome instability in the mammary gland of ACI rats.

Authors:  Kristy Kutanzi; Olga Kovalchuk
Journal:  Cancer Biol Ther       Date:  2013-05-10       Impact factor: 4.742

3.  Breast cancer in the personal genomics era.

Authors:  Rachel E Ellsworth; David J Decewicz; Craig D Shriver; Darrell L Ellsworth
Journal:  Curr Genomics       Date:  2010-05       Impact factor: 2.236

4.  Lunasin-aspirin combination against NIH/3T3 cells transformation induced by chemical carcinogens.

Authors:  Chia-Chien Hsieh; Blanca Hernández-Ledesma; Ben O de Lumen
Journal:  Plant Foods Hum Nutr       Date:  2011-06       Impact factor: 3.921

Review 5.  miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets.

Authors:  Carolyn M Klinge
Journal:  Mol Cell Endocrinol       Date:  2015-02-03       Impact factor: 4.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.